Navigation Links
Promise of genomics research needs a realistic view
Date:2/17/2011

CHAPEL HILL, N.C. - In the ten years since the human genetic code was mapped, expectations among scientists, health care industry, policy makers, and the public have remained high concerning the promise of genomics research for improving health.

But a new commentary by four internationally prominent genetic medicine and bioethics experts cautions against the dangers of inflated expectations an unsustainable genomic bubble and it offers ways to avoid it while still realizing "the true and considerable promise of the genomic revolution."

"This commentary is an attempt to bring some balance to the hopes and claims that swirl around the issue of genomic medicine. It is a cautionary essay that tries to extol the real and formidable potential of genomic medicine but also attempts to counter what we see as exaggerated claims, said lead author medical geneticist James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center.

"Our fear is that if we are uncritical and nave in our enthusiasm for these exciting technologies we risk both diversion of precious resources and premature implementation which could hurt patients - as well as a backlash which will hurt our field," Evans warns.

The commentary appears in the February 18, 2011 issue of the journal Science. Co-authors with Evans are Eric M. Meslin, PhD, director, Center for Bioethics, Indiana University, Indianapolis; Theresa M. Marteau, PhD, FMedSci, professor of health psychology, Kings College, London, UK; and Timothy Caulfield, LL.M., F.R.S.C., Canada Research Chair in Health Law & Policy, University of Alberta, Edmonton, Alberta.

"Breathtaking" is how the authors describe the progress already made in genomic research. But, they caution, the considerable promise of genomics must be evaluated through a realistic lens. Advances in individualized medicine, or pharmacogenetics for example, still require the importance of human behavior in health outcomes: the most powerful predictor of a drug's efficacy depends less on genetics than whether the patient takes the drug.

Among the reasons they cite making genomics the persistent recipient of "hyperbole" and inflated expectations, some are tied to impatience for practical applications, market forces and unbridled (but uncritical) enthusiasm. The news media also is named for "playing an obvious role in the creation of unrealistic hopes."

"These forces act together to produce a kind of "cycle of hype" that drive overly optimistic representations of the research," said co-author Timothy Caulfield.

In their short-list of recommendations for avoiding inflation of the "genomic bubble, Evans and co-authors offer the following: (1) reevaluate funding priorities to stress behavioral and social science research aimed at behavior change for improving health; (2) foster a realistic understanding "of the incremental nature of science and the need for statistical rigor," within the scientific community and that the media make more responsible claims for genomic research; (3) maintain a focus on developing high-quality evidence before integrating good ideas into medical practice.

"By highlighting the risks of continuing to promise results from genomic science, we were hoping to draw attention to a more sustainable approach to reaping the benefits from genomic science," said co-author Eric Meslin.

The authors assert their belief that the current age of genomics will provide great benefits to human health "Ours is not a call to gut existing research or too-rigidly tie funding to degree of disease burden The pursuit of our common goal improved human health demands that we take a hard look at disease causation and order our priorities accordingly."


'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert  

Related medicine news :

1. Innovative virtual reality exposure therapy shows promise for returning troops
2. Peer support offers promise for reducing depression symptoms
3. 2 Experimental Drugs Show Promise for Rare Pancreatic Cancer
4. Electronic cigarettes hold promise as aid to quitting
5. Universal Flu Vaccine Shows Promise in Early Trial
6. Biomarker test shows promise for melanoma diagnosis
7. Stents Show Promise in Treating Brain Blockages
8. Study shows promise for new drug to treat Fragile X
9. New Drug Strategy Shows Promise Against HIV
10. Robotic surgery for head and neck cancer shows promise
11. Y-90 radioembolization offers promise for late-stage liver cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Promise of genomics research needs a realistic view
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... PhD, announced at his Inauguration that WesternU will move forward in bold new ... compass. , WesternU combined Wilson’s Inauguration ceremony with Convocation, the traditional opening of ...
(Date:8/15/2017)... Philadelphia, PA (PRWEB) , ... August 15, 2017 , ... ... they have embarked on a new three-year partnership to expand the City’s commitment to ... AACR supports activities that encourage the public to lead a healthy lifestyle as research ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading dental marketing ... Fast 50 list of Fastest Growing Companies in Tampa Bay. The Tampa Bay Business ... shown three consecutive years of growth. For this year’s award, Progressive Dental ranked number ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Richard Amato is raising ... as a periodontist in Monroe, CT since 1989, Dr. Amato understands that ... is educating his community on how to choose the right clinician for their periodontal ...
(Date:8/15/2017)... Louis Park, Minnesota (PRWEB) , ... August 15, 2017 , ... ... the Hearing Loss Association of America’s HLAA Twin Cities Living Well with Hearing Loss ... Monterey Drive, St. Louis Park, Minnesota. Look for Harris Communications at tables 8 and ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/2/2017)... 2, 2017  Life Flight Network and PeaceHealth Oregon Network ... patient care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, ... and Life Flight Network work collaboratively to move patients who ... when a time sensitive emergency exists. ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology: